M2C is an alliance between EPFL’s Institute of Electrical and Micro Engineering and CSEM, serving as a vehicle for advanced manufacturing innovation, bridging academia and industry.
The official inauguration of the M2C will highlight the center’s capabilities and research directions, providing opportunities for industry to engage.
The inauguration take place at EPFL-NE associated campus in Neuchâtel, Rue de la Maladière 71, 2002 Neuchatel (Switzerland).
This event will be held in French and English.
Tuesday, September 27, 2022. The ceremony starts at 9:30 a.m. and ends at 14:00 p.m.
Welcome coffee
Introduction & Opening
Alain Ribaux, Conseiller d'Etat, Département de l'économie, de la sécurité et de la culture
Ursula Oesterle, EPFL, Vice President for innovation
Alexandre Pauchard, CSEM, CEO
Vivek Subramanian, EPFL, Scientific Director M2C
Dominique Piguet, Medtronic, Engineering Director, and Vincent Collier, Medtronic, Site Leader SMOC
Michele Palmieri, CSEM, Vice President, Micro&Nano Systems
Serge Hauert, Cartier, Manufacturing Organization Director
Konstantin Silberzahn, Sonova, Project Leader R&D
Conclusion & cocktail reception
Registration is free but compulsory for attendees. Please register using the registration form below.
By clicking on ‘Register Now’ (below) you agree to our Online Privacy Policy and will be directed to Microsoft Dynamics 365 Marketing, our online event registration service.
28 January 2025
(Anglais uniquement) Explore FemTech innovation leadership at the BioAlps and HBA Deep Dive in Geneva. Join pioneers, investors, and mentors for insights, discussions, and networking opportunities. Registration is free but limited!
5 December 2024
(Anglais uniquement) Join a free online course by CSEM expert Guillaume Basset on micro-optics and their role in advancing photonic technologies, including imaging systems, Photonic Integrated Circuits (PICs), and diagnostic devices.
13 February 2025 - 14 February 2025
(Anglais uniquement) Save the date! Join CSEM's two-day workshop to network with pharma, biotech, and clinical experts. Explore innovations in advanced in-vitro models, and navigate regulatory challenges in drug development.